Drugs Made In America Acquisition (DMAA)

Currency in USD
10.28
+0.02(+0.20%)
Closed·

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.00M11.92%41.07M
Other Institutional Investors
19.96M59.55%205.18M
Public Companies & Retail Investors
9.56M28.53%98.30M
Total
33.52M100.00%344.56M

Top Institutional Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Drugs Made In America Acquisition LLC12.50%NaNNaN
Karpus Management Inc.6.93%NaNNaN
First Trust Capital Management L.P.6.17%NaNNaN
Polar Multi-Strategy Master Fund5.67%NaNNaN
Polar Asset Management Partners Inc.5.67%NaNNaN
Glazer Capital, LLC5.44%NaNNaN
Hudson Bay Capital Management LP5.37%NaNNaN
Westchester Capital Management, LLC2.92%NaNNaN
Aristeia Capital, LLC2.69%NaNNaN
CrossingBridge Advisors, LLC2.54%NaNNaN

Top Mutual Fund Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Investment Managers Series Trust II - First Trust Merger Arbitrage Fund5.32%NaNNaN
The Merger Fund2.92%NaNNaN
Trust for Professional Managers - RiverPark Strategic Income Fund2.39%NaNNaN
Investment Managers Series Trust II - First Trust Multi-Strategy Fund0.81%NaNNaN
Listed Funds Trust - Horizon Kinetics SPAC Active ETF0.20%NaN684.00
Trust for Professional Managers - CrossingBridge Pre-Merger SPAC ETF0.15%NaN514.00
Fidelity Concord Street Trust - Fidelity Nasdaq Composite Index Fund0.14%NaN467.00
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.